Public Comments to Agencies | Page 5 | Citizens Against Government Waste

Public Comments to Agencies

Agency Comments

Comments to FDA Tobacco Products Scientific Advisory Committee

December 11, 2017 Caryn Cohen, M.S. Office of Science Center for Tobacco Products  Food and Drug Administration  Document Control Center  Building 71, Room G335 10903 New Hampshire Avenue Silver Spring, MD 20993-0002

CAGW Staff December 12, 2017
Agency Comments

CAGW Comments on Federal Motor Vehicle Safety Standards: V2V Communications

September 7, 2017 The Honorable Elaine Chao Secretary U.S. Department of Transportation 1200 New Jersey Avenue, S.E. Washington, D.C. 20590 Ref: Federal Motor Vehicle Safety Standards: V2V Communications Docket No. NHTSA-2016-0126

member (not verified) October 10, 2018
Agency Comments

Centers for Medicare and Medicaid Comments on Biosimilars

August 28, 2017 Centers for Medicare and Medicaid Department of Health and Human Services P.O. Box 8016 Baltimore, Maryland 21244-8013

CAGW Staff August 28, 2017
Agency Comments

FCC Reply Comments on Restoring Internet Freedom (8/15/2017)

[PDF Download]  

CAGW Staff August 15, 2017
Agency Comments

FDA Comments Supporting Tobacco Harm Reduction Products

August 10, 2017 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD  20852

Curtis Kalin August 14, 2017
Agency Comments

FCC Comments on Restoring Internet Freedom (7/14/2017)

[PDF Download]  

CAGW Staff July 14, 2017
Agency Comments

FCC Comments on Wireline Infrastructure

[PDF Download]  

CAGW Staff June 9, 2017
Agency Comments

FCC Comments on Wireless Infrastructure

[PDF Download]  

CAGW Staff June 9, 2017
Agency Comments

FCC Comments on Restoring Internet Freedom

[PDF Download]  

CAGW Staff May 8, 2017
Agency Comments

Supporting the Petitions for Reconsideration of the FCC's Privacy Order

BEFORE THE FEDERAL COMMUNICATIONS COMMISSION Washington, D.C.     In the Matter of )     )  

Deborah Collier March 20, 2017
Agency Comments

Reply Comments Regarding the FCC's Privacy Rules

BEFORE THE FEDERAL COMMUNICATIONS COMMISSION Washington, D.C. In the Matter of Protecting the Privacy of Customers of Broadband and Other Telecommunications Services WC Docket No. 16-106 Reply Comments of 

Deborah Collier March 20, 2017
Agency Comments

Comments to FDA on Labeling for Biosimilar Products

May 31, 2016   Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852.   Re: Docket No. FDA-2016-D-0643 “Labeling for Biosimilar Products; Draft Guidance for Industry”  

Rachel Cole May 31, 2016

Pages

Sign Up For Email Updates


Optional Member Code